ArticleSpine deformity2025
Complications in vertebral body tethering: what are the short term effects on patient reported outcomes?
Article in Spine deformity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Ceiling effects in the EOSQ-24 may limit its ability to assess treatment outcomes in early-onset scoliosis.Spine deformity · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionVertebral body tethering (VBT) has continued to gain popularity for the treatment of idiopathic scoliosis (IS); however, complication and reoperation rates have been reported as high as 25%. There is a paucity of data on the clinical and long-term outcomes of VBT. The purpose of this study is to determine how complications from VBT effect patient quality of life (QOL) up to three years after surgery.
methodsIn this retrospective cohort study, the patients were identified via an analysis of multi-center electronic medical record data from the Pediatric Spine Study Group (PSSG). All patients who underwent VBT for IS were included. The dataset was screened to include only patients who had patient reported outcome data documented both before and after surgery. Patient demographics, surgery dates, complications, Early Onset Scoliosis Questionnaire (EOSQ) scores, and Scoliosis Research Society (SRS) scores were collected. Complications were classified using the modified Clavien-Dindo-Sink (mCDS) complication classification system. The analysis of QOL after surgery was determined comparing survey scores of patients with and without any complication over time. Additional analysis was similarly performed comparing patients with no or mild complications, defined as mCDS grade I and II, to those with severe complications, defined as mCDS grade IIIA or above.
resultsThe study consisted of 339 total surveys from 81 patients with EOSQ data and 293 total surveys from 101 patients with SRS data. Among the 81 patients with EOSQ data, 15 patients experienced a complication, with eight patients suffering a severe complication. Among the 101 patients with SRS data, 42 patients experienced a complication, and 22 patients suffered a severe complication. When comparing patients with a complication to those with without a complication, patients with complications had significantly lower total EOSQ scores at 2, 2.5, and 3 years after surgery (p = 0.009, 0.001, and < 0.001 respectively); however, there was no difference in total SRS scores at any time point. In comparing patients with severe complications to pts with mild complications/no complication, patients with severe complications had significantly worse total EOSQ at 2, 2.5, and 3 years after surgery (p = 0.018, 0.002, & < 0.001) and SRS scores at 2, 2.5, and 3 years after surgery (p = 0.040, 0.018, 0.010).
conclusionPatients with any complication from VBT had worse EOSQ scores at 2 years after surgery. Severe complications (mCDS > IIIA) following VBT manifest with decreasing EOSQ and SRS scores over time and become statistically significant at 2 years and beyond. The magnitude of difference in EOSQ and SRS scores between the groups also increases over time. Longer-term follow-up will ascertain whether these poorer QOL outcomes persist at time points greater than 3 years. Long-term follow up will be important following VBT to compare to PSF for improved patient and parent education.
Indexed as
Identifiers
40637961What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.